About The Study: In this comparative effectiveness trial of behavioral activation psychotherapy (BA) and antidepressant medication management (MEDS) in 416 patients with heart failure experiencing depression, both treatments significantly reduced depressive symptoms by nearly 50% with no statistically significant differences between treatments. BA recipients experienced better physical health-related quality of life, fewer emergency department visits, and fewer days hospitalized. The study findings suggest that patients with heart failure could be given the choice between BA or MEDS to ameliorate depression.
Authors: Waguih William IsHak, M.D., of Cedars-Sinai Medical Center in Los Angeles, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2023.52094)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.52094?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011724
Journal
JAMA Network Open